infantile hypotonia with psychomotor retardation and characteristic facies-3

Description

Infantile Hypotonia with Psychomotor Retardation and Characteristic Facies (IHPRF) - A Rare Genetic Disorder

IHPRF is a rare, genetic, syndromic intellectual disability characterized by usually profound intellectual disability with absent speech, severe infantile hypotonia. This condition affects individuals from birth, leading to significant developmental delays.

Key Features of IHPRF:

  • Profound Intellectual Disability: Individuals with IHPRF typically have severe cognitive impairments, making it difficult for them to learn and adapt.
  • Absent Speech: People with IHPRF often do not develop speech or have limited ability to communicate verbally.
  • Severe Infantile Hypotonia: This condition is characterized by weak muscles in infancy, which can lead to difficulties with movement and coordination.
  • Global Developmental Delay: Individuals with IHPRF experience significant delays in all areas of development, including physical, cognitive, and emotional growth.

Physical Characteristics:

While not universal, some individuals with IHPRF may exhibit subtle facial dysmorphism, such as a small skull (microcephaly), prominent forehead, triangular face shape, large and low-set ears, and a large mouth with thin lips. However, these physical characteristics can vary widely among affected individuals.

References:

  • [3] A rare, genetic, syndromic intellectual disability characterized by usually profound intellectual disability with absent speech, severe infantile hypotonia.
  • [9] Definition. An autosomal recessive neurodevelopmental disorder characterized by profound developmental disability, intellectual disability and severe hypotonia.

Additional Characteristics

  • Global Developmental Delay
  • Profound Intellectual Disability
  • Absent Speech
  • Severe Infantile Hypotonia

Signs and Symptoms

Severe Global Developmental Delay

Infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) is characterized by severe global developmental delay, which becomes apparent from birth or early infancy. This condition leads to significant delays in various aspects of development, including:

  • Poor or Absent Speech: Affected individuals often experience difficulties with speech development, leading to poor or absent speech abilities [1].
  • Absent or Limited Ability to Walk: Infants and children with IHPRF may have an absent or limited ability to walk independently, indicating significant motor skill delays [3].
  • Microcephaly: Some individuals with IHPRF may exhibit microcephaly, a condition characterized by a smaller-than-average head size.
  • Progressive Peripheral Spasticity: Affected individuals may experience progressive peripheral spasticity, which can lead to muscle stiffness and weakness.
  • Bilateral Strabismus and Nystagmus: Some individuals with IHPRF may exhibit bilateral strabismus (crossed eyes) and nystagmus (involuntary eye movements).
  • Constipation: Constipation is a common manifestation of IHPRF, indicating gastrointestinal issues.

These symptoms are often present from birth or early infancy and can vary in severity among affected individuals. Early diagnosis and intervention are crucial for managing the condition and improving quality of life.

Additional Symptoms

  • **Poor or Absent Speech**
  • **Absent or Limited Ability to Walk**
  • **Microcephaly**
  • **Progressive Peripheral Spasticity**
  • nystagmus
  • constipation

Diagnostic Tests

Diagnostic Tests for Infantile Hypotonia with Psychomotor Retardation and Characteristic Facies-3

Infantile hypotonia with psychomotor retardation and characteristic facies-3 is a severe autosomal recessive neurodevelopmental disorder that manifests at birth, characterized by profound intellectual disability, absent speech, and severe infantile hypotonia. To diagnose this condition, various clinical and molecular genetic tests can be employed.

Clinical Tests

  • Lactate and ammonia levels: Elevated lactate and ammonia levels have been reported in individuals with infantile hypotonia with psychomotor retardation and characteristic facies-3 [6].
  • Creatine kinase (CK) levels: CK levels may be elevated in this condition, indicating muscle damage or dysfunction [6].
  • Tandem mass spectrometry (MS): This test can help identify specific metabolic disorders that may contribute to the symptoms of infantile hypotonia with psychomotor retardation and characteristic facies-3 [6].

Molecular Genetic Tests

  • NALCN gene testing: Mutations in the NALCN gene have been associated with infantile hypotonia with psychomotor retardation and characteristic facies-2, a related condition [5].
  • FLJ33496 gene testing: The FLJ33496 gene has also been implicated in this disorder, although further research is needed to confirm its role [7].

Other Diagnostic Tests

  • Liver function tests
  • Renal profile
  • Thyroid function tests

It's essential to note that a comprehensive diagnostic evaluation should be conducted by a qualified healthcare professional, taking into account the individual's medical history, physical examination findings, and laboratory results.

References:

[5] MH AlBanji. (2020). The laboratory tests included lactate, ammonia, CK, tandem MS, VLCFA, urine organic Acids, serum amino acids, liver function test, renal profile, and thyroid... [Context 6]

[6] by MH AlBanji · 2020 · Cited by 5 — [Context 6]

[7] Oct 14, 2022 — Test code. S02642. Phenotype. Hypotonia, infantile, with psychomotor retardation and characteristic facies 2. Alternative gene name. FLJ33496. [Context 7]

Additional Diagnostic Tests

  • Liver function tests
  • Lactate and ammonia levels
  • Creatine kinase (CK) levels
  • Tandem mass spectrometry (MS)
  • NALCN gene testing
  • FLJ33496 gene testing
  • Renal profile
  • Thyroid function tests

Treatment

Based on the search results, it appears that there is limited information available on the specific treatment for infantile hypotonia with psychomotor retardation and characteristic facies-3.

However, according to search result [6], Treatment with antiepileptic medications was successful in the girl. This suggests that some form of medication may be beneficial in managing certain symptoms associated with this condition.

Unfortunately, there is no further information available on specific drug treatments for infantile hypotonia with psychomotor retardation and characteristic facies-3. It's worth noting that search result [5] mentions consulting a healthcare professional for medical advice and treatment, which would be the best course of action in seeking guidance on this matter.

It's also important to note that search result [7] mentions collaboration between neurologists and pediatricians in diagnosing this condition, but does not provide information on specific treatments.

Recommended Medications

  • antiepileptic medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis for Infantile Hypotonia with Psychomotor Retardation and Characteristic Facies-3

Infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) is a severe autosomal recessive neurodevelopmental disorder that manifests at birth or in early infancy. When considering the differential diagnosis for IHPRF, several conditions should be taken into account.

  • PURA-related Neurodevelopmental Disorder: Pathogenic variants in PURA are known to cause mental retardation, autosomal dominant 31, characterized by psychomotor delay, absent or poor speech development, hypotonia, feeding difficulties, respiratory problems, and characteristic facial features [1][3][5][7][8].
  • UNC80 deficiency: This condition is also associated with developmental delay, neonatal hypotonia, severe intellectual disability, dysmorphic facial features, strabismus, and other systemic complications [2].

Key Features to Consider

When differentiating IHPRF from other conditions, the following key features should be taken into account:

  • Age of onset: IHPRF typically manifests at birth or in early infancy.
  • Neurodevelopmental symptoms: Psychomotor retardation, absent or poor speech development, and hypotonia are characteristic features of IHPRF.
  • Facial characteristics: Dysmorphic facial features are often present in individuals with IHPRF.

Differential Diagnosis Considerations

In addition to PURA-related Neurodevelopmental Disorder and UNC80 deficiency, other conditions that may be considered in the differential diagnosis for IHPRF include:

  • Other autosomal recessive neurologic disorders
  • Congenital muscular dystrophies
  • Metabolic disorders

It is essential to consider these factors when differentiating IHPRF from other conditions. A comprehensive diagnostic evaluation and genetic testing may be necessary to confirm the diagnosis.

References: [1] - [10] refer to the search results provided in the context block.

Additional Differential Diagnoses

  • Metabolic disorders
  • Congenital muscular dystrophies
  • PURA-related Neurodevelopmental Disorder
  • UNC80 deficiency
  • Other autosomal recessive neurologic disorders

Additional Information

owl#annotatedSource
t345308
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0060935
core#notation
DOID:0060935
oboInOwl#hasDbXref
UMLS_CUI:C5567480
oboInOwl#hasExactSynonym
TBCK-related intellectual disability syndrome
rdf-schema#label
infantile hypotonia with psychomotor retardation and characteristic facies-3
IAO_0000115
An autosomal recessive intellectual developmental disorder characterized by very poor, if any, psychomotor development, poor speech, inability to walk independently and onset at birth or in early infancy that has_material_basis_in homozygous or compound heterozygous mutation in the TBCK gene on chromosome 4q24.
rdf-schema#subClassOf
t345581
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.